Cargando…

Pharmacological Targeting of BMP6-SMAD Mediated Hepcidin Expression Does Not Improve the Outcome of Systemic Infections With Intra-Or Extracellular Gram-Negative Bacteria in Mice

INTRODUCTION: Hepcidin is the systemic master regulator of iron metabolism as it degrades the cellular iron exporter ferroportin. In bacterial infections, hepcidin is upregulated to limit circulating iron for pathogens, thereby increasing iron retention in macrophages. This mechanism withholds iron...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Alexander, de Souza, Lara Valente, Seifert, Markus, von Raffay, Laura, Haschka, David, Grubwieser, Philipp, Grander, Manuel, Mitterstiller, Anna-Maria, Nairz, Manfred, Poli, Maura, Weiss, Günter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342937/
https://www.ncbi.nlm.nih.gov/pubmed/34368018
http://dx.doi.org/10.3389/fcimb.2021.705087
_version_ 1783734169693585408
author Hoffmann, Alexander
de Souza, Lara Valente
Seifert, Markus
von Raffay, Laura
Haschka, David
Grubwieser, Philipp
Grander, Manuel
Mitterstiller, Anna-Maria
Nairz, Manfred
Poli, Maura
Weiss, Günter
author_facet Hoffmann, Alexander
de Souza, Lara Valente
Seifert, Markus
von Raffay, Laura
Haschka, David
Grubwieser, Philipp
Grander, Manuel
Mitterstiller, Anna-Maria
Nairz, Manfred
Poli, Maura
Weiss, Günter
author_sort Hoffmann, Alexander
collection PubMed
description INTRODUCTION: Hepcidin is the systemic master regulator of iron metabolism as it degrades the cellular iron exporter ferroportin. In bacterial infections, hepcidin is upregulated to limit circulating iron for pathogens, thereby increasing iron retention in macrophages. This mechanism withholds iron from extracellular bacteria but could be of disadvantage in infections with intracellular bacteria. We aimed to understand the role of hepcidin in infections with intra- or extracellular bacteria using different hepcidin inhibitors. METHODS: For the experiments LDN-193189 and oversulfated heparins were used, which interact with the BMP6-SMAD pathway thereby inhibiting hepcidin expression. We infected male C57BL/6N mice with either the intracellular bacterium Salmonella Typhimurium or the extracellular bacterium Escherichia coli and treated these mice with the different hepcidin inhibitors. RESULTS: Both inhibitors effectively reduced hepcidin levels in vitro under steady state conditions and upon stimulation with the inflammatory signals interleukin-6 or lipopolysaccharide. The inhibitors also reduced hepcidin levels and increased circulating iron concentration in uninfected mice. However, both compounds failed to decrease liver- and circulating hepcidin levels in infected mice and did not affect ferroportin expression in the spleen or impact on serum iron levels. Accordingly, both BMP-SMAD signaling inhibitors did not influence bacterial numbers in different organs in the course of E.coli or S.Tm sepsis. CONCLUSION: These data indicate that targeting the BMP receptor or the BMP-SMAD pathway is not sufficient to suppress hepcidin expression in the course of infection with both intra- or extracellular bacteria. This suggests that upon pharmacological inhibition of the central SMAD-BMP pathways during infection, other signaling cascades are compensatorily induced to ensure sufficient hepcidin formation and iron restriction to circulating microbes.
format Online
Article
Text
id pubmed-8342937
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83429372021-08-07 Pharmacological Targeting of BMP6-SMAD Mediated Hepcidin Expression Does Not Improve the Outcome of Systemic Infections With Intra-Or Extracellular Gram-Negative Bacteria in Mice Hoffmann, Alexander de Souza, Lara Valente Seifert, Markus von Raffay, Laura Haschka, David Grubwieser, Philipp Grander, Manuel Mitterstiller, Anna-Maria Nairz, Manfred Poli, Maura Weiss, Günter Front Cell Infect Microbiol Cellular and Infection Microbiology INTRODUCTION: Hepcidin is the systemic master regulator of iron metabolism as it degrades the cellular iron exporter ferroportin. In bacterial infections, hepcidin is upregulated to limit circulating iron for pathogens, thereby increasing iron retention in macrophages. This mechanism withholds iron from extracellular bacteria but could be of disadvantage in infections with intracellular bacteria. We aimed to understand the role of hepcidin in infections with intra- or extracellular bacteria using different hepcidin inhibitors. METHODS: For the experiments LDN-193189 and oversulfated heparins were used, which interact with the BMP6-SMAD pathway thereby inhibiting hepcidin expression. We infected male C57BL/6N mice with either the intracellular bacterium Salmonella Typhimurium or the extracellular bacterium Escherichia coli and treated these mice with the different hepcidin inhibitors. RESULTS: Both inhibitors effectively reduced hepcidin levels in vitro under steady state conditions and upon stimulation with the inflammatory signals interleukin-6 or lipopolysaccharide. The inhibitors also reduced hepcidin levels and increased circulating iron concentration in uninfected mice. However, both compounds failed to decrease liver- and circulating hepcidin levels in infected mice and did not affect ferroportin expression in the spleen or impact on serum iron levels. Accordingly, both BMP-SMAD signaling inhibitors did not influence bacterial numbers in different organs in the course of E.coli or S.Tm sepsis. CONCLUSION: These data indicate that targeting the BMP receptor or the BMP-SMAD pathway is not sufficient to suppress hepcidin expression in the course of infection with both intra- or extracellular bacteria. This suggests that upon pharmacological inhibition of the central SMAD-BMP pathways during infection, other signaling cascades are compensatorily induced to ensure sufficient hepcidin formation and iron restriction to circulating microbes. Frontiers Media S.A. 2021-07-23 /pmc/articles/PMC8342937/ /pubmed/34368018 http://dx.doi.org/10.3389/fcimb.2021.705087 Text en Copyright © 2021 Hoffmann, de Souza, Seifert, von Raffay, Haschka, Grubwieser, Grander, Mitterstiller, Nairz, Poli and Weiss https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Hoffmann, Alexander
de Souza, Lara Valente
Seifert, Markus
von Raffay, Laura
Haschka, David
Grubwieser, Philipp
Grander, Manuel
Mitterstiller, Anna-Maria
Nairz, Manfred
Poli, Maura
Weiss, Günter
Pharmacological Targeting of BMP6-SMAD Mediated Hepcidin Expression Does Not Improve the Outcome of Systemic Infections With Intra-Or Extracellular Gram-Negative Bacteria in Mice
title Pharmacological Targeting of BMP6-SMAD Mediated Hepcidin Expression Does Not Improve the Outcome of Systemic Infections With Intra-Or Extracellular Gram-Negative Bacteria in Mice
title_full Pharmacological Targeting of BMP6-SMAD Mediated Hepcidin Expression Does Not Improve the Outcome of Systemic Infections With Intra-Or Extracellular Gram-Negative Bacteria in Mice
title_fullStr Pharmacological Targeting of BMP6-SMAD Mediated Hepcidin Expression Does Not Improve the Outcome of Systemic Infections With Intra-Or Extracellular Gram-Negative Bacteria in Mice
title_full_unstemmed Pharmacological Targeting of BMP6-SMAD Mediated Hepcidin Expression Does Not Improve the Outcome of Systemic Infections With Intra-Or Extracellular Gram-Negative Bacteria in Mice
title_short Pharmacological Targeting of BMP6-SMAD Mediated Hepcidin Expression Does Not Improve the Outcome of Systemic Infections With Intra-Or Extracellular Gram-Negative Bacteria in Mice
title_sort pharmacological targeting of bmp6-smad mediated hepcidin expression does not improve the outcome of systemic infections with intra-or extracellular gram-negative bacteria in mice
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342937/
https://www.ncbi.nlm.nih.gov/pubmed/34368018
http://dx.doi.org/10.3389/fcimb.2021.705087
work_keys_str_mv AT hoffmannalexander pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT desouzalaravalente pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT seifertmarkus pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT vonraffaylaura pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT haschkadavid pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT grubwieserphilipp pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT grandermanuel pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT mitterstillerannamaria pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT nairzmanfred pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT polimaura pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice
AT weissgunter pharmacologicaltargetingofbmp6smadmediatedhepcidinexpressiondoesnotimprovetheoutcomeofsystemicinfectionswithintraorextracellulargramnegativebacteriainmice